AbbVie and Gilead are going back to their roots and leaning on their established areas of expertise to set themselves up for ...

Omvoh’s label expansion is important progress for Eli Lilly as it works to diversify its portfolio beyond obesity, according ...

If you live in the United States, you’ve likely seen drug commercials like this one: “If you’re living with moderate to severe plaque psoriasis or active psoriatic arthritis, symptoms can sometimes ...

As Medscape marks its 30th anniversary, we are collaborating with physicians, scientists, and futurists from around the globe to boldly envision the future of medicine in the year 2050.

The recommended dose for Skyrizi is 150 mg – administered by two subcutaneous injections every 12 weeks following two initiation doses at week 0 and 4. It can be administered in-office or by ...

Additionally, AbbVie is an exceptional income stock. It's a Dividend King, with 52 consecutive years of payout increases including the time it spent under the wing of its former parent company, Abbott ...

Sales of Skyrizi and Rinvoq grew by 50% and 45%, respectively -- much faster than any other medicine in the company's portfolio, even though they generate the highest sales aside from Humira.

Not only are pharmaceutical stocks excellent defensive investments in an uncertain economy, but some pharma stocks also pay ...

The company’s follow-up drug Skyrizi is a key plank in AbbVie’s strategy to negotiate the $20 billion patent cliff from Humira, which has already seen sales decline outside of the US where it ...

For over forty years, our renowned Centre for Medical Education (CME) has been shaping the way medicine and other allied professions are taught. Our scientists are at the forefront of understanding ...